Prioritis, an IQVIA business is a global provider in market access solutions for pharmaceutical, biotechnology and medical devices.
With strategic HTA, pricing and reimbursement capabilities, Prioritis advises its clients at all stages of a product development and commercialization. Its expertise covers France and top European and international pharmaceutical markets.
Prioritis’ global platforms, Prismaccess/Evalumade and PrismHEOR, deliver a unique integrated service on HTA, reimbursement and economic insights, supporting decision makers at all stages of their drug’s life.
Prioritis has operations in France and in the UK, and provides its know-how to most of the top 50 pharma and healthcare companies.
Prioritis provides strategic expertise and technical support to global market access and pricing departments. Present at each stage of the reimbursement process, Prioritis’ expertise in value based pricing and market access enables the company to deliver key advice…
Prioritis undertakes support for pricing and reimbursement processes for new innovative drugs, extension of indications and reassessment of therapeutic areas. The company approach is highly appreciated by leading global and European heads of market access and our methodology has become the industry standard…
Prismaccess and PrismHEOR deliver exhaustive reliable and global data on HTA, reimbursement, pricing and economic decisions.
A unique online service dedicated to market access, HEOR and pricing departements.